Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03120598 · ClinicalTrials.gov registry record · NA

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

A NA study, sponsored by RTI International.

Completed
Registry status
NA
Development phase
190
Enrollment target

NCT03120598: Completed NA study, sponsored by RTI International.

NCT03120598 is a NA study that has completed, run by RTI International. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03120598, a NA study, has completed, sponsored by RTI International.

COMPLETED
Registry status
NA
Development phase
190 participants
Enrollment target

Study Summary

A cluster randomized experiment focused on testing the extent to which the organization-focused Implementation \& Sustainment Facilitation (ISF) strategy is an effective adjunct to the staff-focused Addiction Technology Transfer Center (ATTC) strategy.

Primary Outcome

A continuous measure representing the number of days between completion of the training workshop by targeted staff and targeted staff's demonstration of proficiency in the motivational interviewing-based brief intervention.

Interventions

  • BEHAVIORAL ATTC strategy
  • BEHAVIORAL ISF strategy

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2015-01-05
Est. Completion 2018-08-22
Phase NA
RTI International

45 total trials

What the finished NCT03120598 record still lists

NCT03120598 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which ATTC strategy is the first listed.

NCT03120598 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03120598 about?

NCT03120598 is a clinical study titled "Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment". A cluster randomized experiment focused on testing the extent to which the organization-focused Implementation \& Sustainment Facilitation (ISF) strategy is an effective adjunct to the staff-focused Addiction Technology Transfer Center (ATTC) strategy.

What is the current status of trial NCT03120598?

This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2015-01-05. Estimated completion is 2018-08-22.

What interventions are being tested in trial NCT03120598?

The interventions under investigation include: ATTC strategy (BEHAVIORAL), ISF strategy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03120598?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03120598's enrollment target sits among peer trials

190 574th of 2000 higher than 1,425 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03257033 · 190 participants · Phase 3

    Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

  • NCT03642028 · 190 participants · Phase 4

    Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

  • NCT04015609 · 190 participants · NA

    Psychotherapy Intervention for Latinos With Advanced Cancer

  • NCT04284397 · 190 participants · Early Phase 1

    Identification of Critical Thermal Environments for Aged Adults

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03120598, the US trial registry maintained by the National Library of Medicine. NCT03120598 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.